Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis

BACKGROUND: The clinical impact of neutralizing antibodies against interferon-beta (NAb) is controversial. Their presence can lead to a decrease in interferon-beta (IFNβ) efficacy. Fatigue reported in patients with multiple sclerosis (MS) may be associated with an unfavorable clinical course. We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Manceau, Philippe, Latarche, Clotilde, Pittion, Sophie, Edan, Gilles, de Sèze, Jérôme, Massart, Catherine, Debouverie, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256902/
https://www.ncbi.nlm.nih.gov/pubmed/25433670
http://dx.doi.org/10.1186/s12883-014-0215-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256902/
https://www.ncbi.nlm.nih.gov/pubmed/25433670
http://dx.doi.org/10.1186/s12883-014-0215-y

Ejemplares similares